Application

SQUAD

Seqirus UK Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90302869
Filing Date: 11/06/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90302869
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\903\028\90302869\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT SQUAD
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) purple, gray and blue is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the stylized word "SQUAD" that appears in blue. Above the word "SQUAD" are three hexagons arranged horizontally. In the center is a gray hexagon with a gray circle above it, overlapping with left side of the gray hexagon is a smaller purple hexagon with a purple circle above it, and overlapping with the right side of the gray hexagon is a smaller blue hexagon with a blue circle above it. The white in the mark represents merely background and is not claimed as part of the mark.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 2091 x 1181
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Seqirus UK Limited
*MAILING ADDRESS Point, 29 Market Street
*CITY Maidenhead, Berkshire
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United Kingdom
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
SL68AA
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE a limited company organized under the laws of England and Wales
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED United Kingdom
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Conducting clinical trials for coronavirus and COVID-19 vaccines; providing information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Nancy Sabarra
ATTORNEY DOCKET NUMBER SEQI 2011145
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Fross Zelnick Lehrman & Zissu, P.C.
STREET 151 West 42nd St., 17th Fl.
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10036
PHONE 212-813-5900
EMAIL ADDRESS Sabarra-Docket@fzlz.com
OTHER APPOINTED ATTORNEY Lawrence E. Apolzon, Andrew N. Fredbeck, Allison Strickland Ricketts, Karen Lim, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger
DOMESTIC REPRESENTATIVE INFORMATION
NAME Fross Zelnick Lehrman & Zissu, P.C.
STREET 151 West 42nd St., 17th Fl.
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 10036
PHONE 212-813-5900
EMAIL ADDRESS Sabarra-Docket@fzlz.com
CORRESPONDENCE INFORMATION
NAME Nancy Sabarra
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE Sabarra-Docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Nicole Rizzo Smith/
SIGNATORY'S NAME Nicole Rizzo Smith
SIGNATORY'S POSITION Authorized Representative
DATE SIGNED 11/05/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90302869
Filing Date: 11/06/2020

To the Commissioner for Trademarks:

MARK: SQUAD (stylized and/or with design, see mark)
The literal element of the mark consists of SQUAD. The color(s) purple, gray and blue is/are claimed as a feature of the mark. The mark consists of the stylized word "SQUAD" that appears in blue. Above the word "SQUAD" are three hexagons arranged horizontally. In the center is a gray hexagon with a gray circle above it, overlapping with left side of the gray hexagon is a smaller purple hexagon with a purple circle above it, and overlapping with the right side of the gray hexagon is a smaller blue hexagon with a blue circle above it. The white in the mark represents merely background and is not claimed as part of the mark.
The applicant, Seqirus UK Limited, a a limited company organized under the laws of England and Wales legally organized under the laws of United Kingdom, having an address of
      Point, 29 Market Street
      Maidenhead, Berkshire SL68AA
      United Kingdom
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  Conducting clinical trials for coronavirus and COVID-19 vaccines; providing information about the results of clinical trials for coronavirus and COVID-19 vaccines; providing medical and scientific research information in the field of coronavirus and COVID-19 vaccines and coronavirus and COVID-19 vaccine clinical trials
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: Nancy Sabarra. Other appointed attorneys are Lawrence E. Apolzon, Andrew N. Fredbeck, Allison Strickland Ricketts, Karen Lim, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger. Nancy Sabarra of Fross Zelnick Lehrman & Zissu, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      151 West 42nd St., 17th Fl.
      New York, New York 10036
      United States
      212-813-5900(phone)
      Sabarra-Docket@fzlz.com
The docket/reference number is SEQI 2011145.
Nancy Sabarra submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Fross Zelnick Lehrman & Zissu, P.C.
      151 West 42nd St., 17th Fl.
      New York New York 10036
      United States
      212-813-5900(phone)
      Sabarra-Docket@fzlz.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.


The applicant's current Correspondence Information:
      Nancy Sabarra
       PRIMARY EMAIL FOR CORRESPONDENCE: Sabarra-Docket@fzlz.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Nicole Rizzo Smith/   Date: 11/05/2020
Signatory's Name: Nicole Rizzo Smith
Signatory's Position: Authorized Representative
Payment Sale Number: 90302869
Payment Accounting Date: 11/06/2020

Serial Number: 90302869
Internet Transmission Date: Fri Nov 06 09:45:34 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2020110609453412
6863-90302869-7506546e9fda88720669d6431c
a2596698519febd2718d93e2e435ad42f133cfaa
b-DA-45332355-20201105164329452126

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed